Serial ECGs can reveal far more than simple pattern recognition. A reminder that dynamic ECG interpretation remains central to complex arrhythmia diagnosis.
https://t.co/V03kpDLsr6
#CardioTwitter#ECG#EPeeps#Electrophysiology#VT#AF@Rajiv_EP
Thanks @drjohnm! Indeed much to say that the 750 word count limit would not allow. Many overly simplified positive reactions to the trial here on X are disconcerting (albeit sadly not surprising). I would encourage everyone to read the trial carefully to form their own conclusions, and I hope my editorial helps. @UCSFCardiology
#WhyCMR by LGE in sarcoidosis, new precision in prognosis? Large #UK cohort of biopsy-proven cardiac sarcoidosis finds that LGE extent was an independent predictor of VAs or device therapy. #JACCIMG offers a novel approach to arrhythmic risk stratification https://t.co/PDK5fsXjMt
What defines an AFib Center of Excellence?
HRS lays it out in a new consensus statement: “Criteria for the Establishment of Atrial Fibrillation Centers of Excellence.”
Chaired by Drs. @TJaredBunch and @deering_f, this multidisciplinary effort offers a checklist of criteria that care teams can strive for to elevate their AFib care.
Read the full paper: https://t.co/pbGqPL89Kz
#AFib #EPeeps #HRS2025
This is another huge takeaway from the OPTION trial: how low the incidence of stroke is post modern AF ablation.
The CHADSVA tool is meaningless in this cohort, where AF burden has been substantially reduced with ablation
The long-term incidence of stroke in AF is low, especially after ablation of paroxysmals. Stroke scores are from another era and were not developed or validated in this population: CHADSVASC was derived from 20-year old data with ONE YEAR of follow-up.
The treatment effect of statins, BP control, and reduced risk of HF may be contributing more to fewer strokes in AF. Recent AF screening trials have all shown stroke event rates lower than historical. We need a clever and cautious way to redefine risk stroke in contemporary AF patients before assuming that the historical reduction is all from therapy. #AHA24
Congratulations to @RivardLena on the @AHAScience presentation of the BRAIN-AF study results.
Major observation is that cognitive decline occurs in many « low risk » AF patients.
Unfortunately, Rivaroxaban 15 mg daily did not impact this risk in this double-dummy RCT.
Untreated atrial fibrillation raises risks of dementia, heart failure & stroke—25% occur before diagnosis.
⚠️Don’t let a stroke be your first sign of AF.
Watch @hearts4heart’s video to learn about AF symptoms and visit https://t.co/f996f6fkp3
#hearts4heart#atrialfibrillation
#APHRS2024 - LBCT Session
🗓️29/09 at 1:30pm 📍C3.4 | C3.5
Get ready for one of the most anticipated session of the event – Late-Breaking Clinical Trials! 🚨📊 Join us as leading experts reveal the latest groundbreaking studies that are set to transform patient care and medical practice. Whether you're a clinician, researcher, or healthcare professional, this session will offer invaluable insights into cutting-edge innovations and clinical breakthroughs.
#MedicalBreakthroughs #HealthcareInnovation #CardioTwitter #ResearchInMedicine
We looked at this is AFFIRM & AF-CHF almost 10 years ago
HR affects prognosis differently in AF vs sinus.
In sinus more related to mortality.
In af more related to hospitalisation
In AF - lower HR wasn’t better.
https://t.co/AAKtebJU9G
Insta-termination with 1st epi RF over incomplete endo anterior line at Bachmann/VOM junction.
A fully percutaneous catheter-based MAZE is within reach. #AFin3D